Evidence map›Paper›PMID 37509571›Full record

ArticleBiomedicines2023

Nano-Catechin Gel as a Sustained Release Antimicrobial Agent against Clinically Isolated

Anahita Javadkhani, Behnaz Shokouhi, Amin Mosayebzadeh, Samira Safa, Mahsa Fahimi, Simin Sharifi, Solmaz Maleki Dizaj, Sara Salatin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Determination of Potential Inhibitors againstCurrent pharmaceutical design · 2026
    Review
  2. Review
  3. Identification of potential inhibitors againstJournal of enzyme inhibition and medicinal chemistry · 2024
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anahita JavadkhaniDental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran.
Behnaz ShokouhiDental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran.
Amin MosayebzadehDepartment of Dental Biomaterials, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran.
Samira SafaDepartment of Dental Biomaterials, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran.
Mahsa FahimiDepartment of Dental Biomaterials, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran.
Simin SharifiDental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran.ORCID 0000-0002-3020-3779
Solmaz Maleki DizajDental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran.ORCID 0000-0003-4759-7222
Sara SalatinNeurosciences Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran.
Tabriz University of Medical Sciences · IR

Funding

Tabriz University of Medical Sciences 68491
6 · The paper itself

Abstract

During the last two decades, new drug delivery strategies have been invented that have been able to solve microbial resistance against antibiotics. The goal of the current report was to assess the antimicrobial effects of nano-catechin gels against clinically isolated

Indexed as

antimicrobial effectscatechinclinically isolatednano-catechinPorphyromonas gingivalis

Identifiers

PMID37509571
PMCPMC10377056
OpenAlexW4383721758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.